PARP1 can inhibit the expression of PD-L1 on the surface of TNBC cells by interacting with the nucleic acid-binding domain of nucleophosmin, thus playing a key role in the tumor-related immune escape of TNBC (Qin et al., 2020). The gene discussed is CD274; the disease is neoplasm.